The process by which molecular oxygen is activated to enable it to function as an electron acceptor in biology is poorly understood. The quinoprotein copper-containing amine oxidase (CuAO) catalyses the conversion of primary amines into aldehydes. As well as copper, the enzyme contains an organic cofactor, 2,4,5-trihydroxyphenylalanine quinone (TPQ). Following the formation of aldehyde, the enzyme is left as the twoelectron reduced aminoquinol form. Reoxidation of the enzyme back to the resting state uses molecular oxygen, which is reduced to H 2 O 2 in the process, with the additional release of NH 3 . To understand the structural basis of oxygen activation in Escherichia coli CuAO (ECAO), catalytically competent crystals were used to trap catalytic intermediates by exposing then to amine substrate and then freeze-trapping under aerobic and anaerobic conditions. Single-crystal visible microspectrophotometry was used to probe the oxidation state of the quinone in the intermediates, as TPQ exhibits a rich palette of colour changes during catalytic turnover. This review will focus on one of these structures, that of the rate-determining species in the crystal under steady-state conditions. This structure has revealed many details regarding oxygen activation in ECAO, including the site of dioxygen binding, and the proton-transfer pathways involved in H 2 O 2 formation.
Introduction
Copper-containing amine oxidases (CuAOs) are a ubiquitous family of enzymes found from bacteria all the way to mammals [1] . The human genome has revealed the presence of three distinct CuAO genes (also known as semicarbazidesensitive amine oxidases, or SSAOs) [2] . Recently the human kidney diamine oxidase has been expressed and characterized in vitro [3] . This enzyme is also highly expressed in placenta and the small intestine, as well as kidney, but is also found at lower levels in other tissues, including the liver and lungs. Its favoured substrates appear to be histamine, 1-methylhistamine and putrescine in that order, and its physiological function currently remains elusive. Perhaps most intriguing is the CuAO vascular adhesion protein-1 (VAP-1) [4] . This membrane-bound CuAO is located on the cell surface of endothelial cells lining vascular tissue, and also in the liver, and is involved in leucocyte trafficking. VAP-1 is directly responsible for the reversible tethering and rolling of leucocytes on the vascular walls, which is the initial step in the transmigration of leucocytes into the surrounding tissue. A cleaved soluble form of VAP-1 is also present in blood plasma. Recently the CuAO located in adipocyte membranes has been linked to glucose transport via the GLUT-4 pathway [5] [6] [7] [8] [9] [10] .
Key words: catalytic intermediate, copper-containing amine oxidase, oxygen activation, quinoprotein, X-ray crystallography. Abbreviations used: CuAO, copper-containing amine oxidase; TPQ, 2,4,5-trihydroxyphenylalanine quinone; ECAO, Escherichia coli copper-containing amine oxidase; VAP-1, vascular adhesion protein-1; AGE, advanced glycation end-product; βPEA, β-phenylethylamine. 1 e-mail wilmo004@umn.edu Several pathologies have been linked to human CuAOs. Increased CuAO activity is linked to vascular changes in congestive heart disease [11] and late-diabetic complications [12] [13] [14] . In diabetes the production of methylglyoxal and formaldehyde from aminoacetone and methylamine respectively, two of the best substrates for human plasma CuAO, leads to the production of advanced glycation end-products (AGEs) causing cross-linking in vascular tissues, such as the aorta, leading to angiopathy and cardiovascular disorders [15, 16] . The production of AGEs maps to the tissue-specific levels of CuAOs, and levels of the enzymes themselves are increased in diabetic patients. Recently, protein cross-linking from increased formaldehyde production by cerebrovascular CuAO has been linked to plaque formation in Alzheimer's disease [17] .
CuAOs convert primary amines into aldehydes, also generating H 2 O 2 and NH 3 [18] . The enzyme is a 150-190 kDa homodimer containing two distinct active sites [19] [20] [21] [22] . Each active site contains a copper ion and a protein-derived cofactor, 2,4,5-trihydroxylphenylalanine quinone (TPQ), which is derived from the post-translational modification of an endogenous tyrosine (Scheme 1, species 1) [23] . In the case of Escherichia coli CuAO (ECAO), the preferred substrates are aromatic monoamines, such as β-phenylethylamine (βPEA), and it enables the bacterium to utilize these compounds as sources of carbon and nitrogen.
Numerous biochemical studies have identified that the catalysed reaction occurs in two halves; a reductive half, which proceeds via a Schiff-base intermediate and leads to the production of product aldehyde, and an oxidative
Scheme 1 Scheme of the reaction catalysed by ECAO
The reductive half-reaction is represented by species 1-5. The TPQ cofactor in the resting enzyme (1) undergoes nucleophilic attack at the C-5 position by the primary amine substrate [shown as a substituted (X) phenylmethylamine] to form a Schiff base (2) . The catalytic base (Asp-383) abstracts the pro-S proton resulting in a carbanionic intermediate (3) , which rearranges to form the product Schiff base (4) . Hydrolysis leads to the release of product aldehyde and the formation of the aminoquinol (5), which is often in equilibrium with a small amount of semiquinone/Cu(I) (6 half, which regenerates the quinone from the two-electron reduced aminoquinol form of the enzyme using molecular oxygen, releasing H 2 O 2 and NH 3 (Scheme 1) [18] . However, the oxidative half-reaction has remained elusive in terms of oxygen activation and the relative roles of both the copper and TPQ in this process. Upon anaerobic amine substrate reduction, the aminoquinol/Cu(II) couple is often found to be in equilibrium with the semiquinone/Cu(I), demonstrating that an electron can be transferred between the two redox centres [24] . This suggested that Cu(I) was the site of molecular oxygen binding. This has recently been challenged, and it now seems clear that copper is not required to change redox state during catalysis, and it has been suggested that its principal role is in electrostatic stabilization [25, 26] . To examine structurally the site of dioxygen binding, intermediates in catalytically competent crystals of ECAO were trapped, both anaerobically and aerobically, and then their structures solved by X-ray crystallography [27, 28] .
Combining X-ray crystallography and visible single-crystal spectroscopy [28, 29] Protein crystals are, on average, composed of 60% solvent. This means that large solvent channels run through the crystal. This enables small molecules, such as substrate, to be diffused into the crystals. Providing that optimum conditions for catalysis, such as pH, can be tolerated by the crystals, the active sites are not occluded through crystal contacts and no large structural changes occur during turnover, enzymes can remain catalytically active in the crystalline state. However, due to the solution conditions required to maintain crystal integrity, and the restraints imposed by the crystal lattice, the rates of individual catalytic steps can be significantly perturbed. In addition, there is always the possibility of invoking a pathway that is different to the one observed in solution. Therefore, when trying to trap intermediates in enzyme crystals, how does one identify what is actually in the crystal? The electron density produced by the X-ray crystallographic experiment is an average of the structures of all the molecules in the crystal. In practice this means that at least 80% of the molecules must be in the same state to unambiguously assign the electron density to a single species. The rate of diffusion of substrates into the crystals becomes a limiting step, and species will only build up in crystals if their conversion rates are significantly lower than diffusion, or if some type of 'trap' can be used to pause the reaction at a specific point.
In the case of CuAO, the TPQ cofactor changes colour during the reaction. In terms of the oxidative half-reaction, the two-electron reduced aminoquinol is colourless [30] , the one-electron reduced semiquinone is yellow [24] and the resting quinone is pink [31] . The postulated oxidized iminoquinone is also expected to be colourless due to the hydrogen bonding observed in the active site (Scheme 1) [32] . Thus single-crystal visible spectroscopy can define the species present in the crystal.
ECAO turns over βPEA at a rate of 118 molecules/s in solution [33] . Surprisingly, it took 9 min to reach steady state upon flowing βPEA aerobically over the crystals. Before steady state had been reached, the yellow semiquinone was observed. The final steady-state species was colourless, suggesting that either one or both of the aminoquinol and iminoquinone were present [29] . The order of appearance of the different intermediate spectral features matched the order in which they appeared in solution. The rates in the reductive half-reaction appeared to be higher than the rate of diffusion, but the slowing down of the oxidative half-reaction to such a large extent in the crystals was a surprise. By flash-cooling the crystals in liquid nitrogen at steady state, the 'pause' button could be pushed on the reaction, locking the molecules into their steady-state structure. In addition, the ECAO crystals could be exposed to βPEA in an anaerobic glovebox, which locked the enzyme in its aminoquinol form, and flash-cooling in liquid nitrogen before removal from the glovebox prevented oxidation when moving the crystals into an aerobic environment [27] .
Structure of the trapped steady state in ECAO crystals [27]
The structure (to 2.1 Å resolution) represented a single species, that of the iminoquinone, which had become the rate-determining species in the crystal. The reaction in solution follows a 'ping-pong' mechanism, i.e. the product aldehyde is released prior to the start of the oxidative halfreaction. The surprise was the presence of the product phenylacetaldehyde in the back of the active site in all structures solved from the oxidative half-reaction. This explained the large rate reduction in the oxidative half of the reaction. The substrate/product entry/exit channel is very spatially tight in ECAO, and the domain that forms the back of this channel is involved in a crystal contact. It appears that the restriction to the movement of this domain imposed by the crystal lattice makes it hard for the product aldehyde to exit the active site. Figure 1 shows the main features and interactions observed in the steady-state structure. Dioxygen is observed bound between the copper ion and the O-2 position of the iminoquinone, which represents the first direct visualization of dioxygen bound to a mononuclear copper centre in an enzyme. This position in the resting and anaerobically substrate-reduced enzymes is occupied by a water molecule, which bridges between the copper ion and O-2 of the cofactor. The dioxygen is almost 'side-on' to the copper, but at a long distance (2.8 and 3.0 Å from the copper to either end of the dioxygen), which suggests that the dioxygen is the peroxide product, and fits both with the iminoquinone state of the cofactor and the suggestion that the copper ion is principally playing an electrostatic role rather than acting as a redox centre. This is further suggested by the complex between NO (an oxygen mimic) and the anaerobic substratereduced enzyme, where this time the diatomic is 'bent' to the copper ion (117
• angle), but again at a long distance (2.4 Å ), and appears to be interacting more strongly with the O-2 of the aminoquinol than the copper ion.
Electron density for a water molecule (W4 in Figure 1 ) has appeared in a perfect position for nucleophilic attack at the C-5 position of the cofactor to release NH 3 . This water is hydrogen-bonded to a conserved Asp residue (Asp-383), which acts as the catalytic base during the reductive half-reaction (Scheme 1). The product phenylacetaldehyde is also hydrogen-bonded to this Asp residue, meaning that the acid group must be protonated. This suggests that product aldehyde needs to exit the active site to enable deprotonation of Asp, which activates the water, W4, for attack in an acid-mediated hydrolysis to release NH 3 and regenerate the quinone.
The two protons required to generate the H 2 O 2 come from substrate via the O-4 position of the cofactor, and probably a proton left on the O-2 position by the bridging water ligand when it is displaced by dioxygen. Direct proton transfer between cofactor O-2 and the distal end of dioxygen is obvious, and the proton transfer from cofactor O-4 to the proximal end of dioxygen would seem to have a pathway via the conserved Tyr-369 and a water molecule (W2; Figure 1 ) that is conserved in all known CuAO structures [19] [20] [21] [22] .
In summary, this structure has demonstrated the site of dioxygen binding, bridging between the copper ion and the cofactor, which potentially enables it to be reduced by electrons from either, suggesting that molecular oxygen could indeed be principally activated by the aminoquinol rather than the chemically expected Cu(I). Conserved proton-transfer pathways are evident. The release of NH 3 appears to be an acid-mediated hydrolysis reaction involving the catalytic base from the reductive half-reaction (Asp-383). This work demonstrates the power of combining cryocrystallography and single-crystal spectroscopy to provide a structural basis for understanding processes such as oxygen activation in enzymes at the molecular level.
